Upstream Bio Inc. (UPB)
NASDAQ: UPB
· Real-Time Price · USD
22.28
0.59 (2.72%)
At close: Oct 16, 2025, 3:59 PM
22.40
0.54%
After-hours: Oct 16, 2025, 05:01 PM EDT
2.72% (1D)
| Bid | 20.33 |
| Market Cap | 1.2B |
| Revenue (ttm) | 2.72M |
| Net Income (ttm) | -104.47M |
| EPS (ttm) | -6.18 |
| PE Ratio (ttm) | -3.61 |
| Forward PE | -6.77 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 23.83 |
| Volume | 391,381 |
| Avg. Volume (20D) | 495,053 |
| Open | 21.79 |
| Previous Close | 21.69 |
| Day's Range | 21.39 - 22.39 |
| 52-Week Range | 5.14 - 29.46 |
| Beta | 1.78 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for UPB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsUpstream Bio Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
7 months ago
+7.83%
Upstream Bio shares are trading lower after the co...
Unlock content with
Pro Subscription
11 months ago
+8.91%
Upstream shares are trading higher after multiple firms initiated coverage on the stock with an Overweight rating.
